<DOC>
	<DOC>NCT02922972</DOC>
	<brief_summary>The aim of this prospective study is to assess the efficacy of autologous Platelet Rich Plasma prepared with RegenKit-BCT in the prevention and the treatment of keloid scars refractory to conventional treatments. Fifteen patients were included and received three PRP injection sessions with a one-month interval. The outcomes were assessed at baseline (before treatment), 3, 6, 12 and 24 months after the last injection session. Safety was assessed by reported adverse event analysis.</brief_summary>
	<brief_title>Treatment of Keloid Scar by Autologous Platelet Rich Plasma Obtained With RgenKit-BCT</brief_title>
	<detailed_description />
	<mesh_term>Keloid</mesh_term>
	<criteria>Patients with keloid scars refractory to conventional treatments. The indication of PRP injection was based on the absence of response to corticosteroids alone or in combination with surgery after 4 sessions of infiltration and/or absence of response to other therapies. Patients younger than 18 years Pregnancy or breastfeeding Patients suffering from anemia patients with active skin disorder infection including active hepatitis or human infection virus infection Autoimmune disease such as Hashimoto, rheumatoid arthritis. Malignancy with or without metastatic disease Chemotherapy Anticoagulant therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Keloid scar</keyword>
	<keyword>Wound healing</keyword>
	<keyword>Platelet-Rich Plasma</keyword>
	<keyword>RegenLab</keyword>
</DOC>